Skip to main content
SpringerLink
Log in

Understanding and Addressing Hair Disorders in Transgender Individuals

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

In the United States, an increasing number of individuals are identifying as transgender. Males at birth who identify as females are called male-to-female (MTF) transgender individuals or trans women, and females at birth who identify as males are called female-to-male (FTM) transgender individuals or trans men. The transgender patient population possess unique health concerns disparate from those of the general populace. Exogenous hormone therapy for transgender patients leads to changes in the distribution and pattern of hair growth. Exogenous testosterone can lead to male pattern hair loss and hirsutism, while estrogen therapy usually results in decreased facial and body hair growth and density. A thorough understanding of the hormonal treatments that may be used in transgender individuals as well the unique and complex biologic characteristics of the hair follicle is required for appropriate diagnosis, counseling and treatment of patients. The aim of this article is to provide a framework for understanding hair disorders in transgender individuals and effective treatment options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Institute TW, Flores AR, Herman JL, Gates GJ, Brown TNT. How many adults identify as transgender in the United States? Williams Inst. [Internet]. 2016 [cited 2017 Mar 29]. Available from: http://escholarship.org/uc/item/2kg9x2rk.

  2. Steinmetz K. The Transgender Tipping Point [Internet]. Time. 2014 [cited 2017 Mar 29]. Available from: http://time.com/135480/transgender-tipping-point/.

  3. Reisner SL, Poteat T, Keatley J, Cabral M, Mothopeng T, Dunham E, et al. Global health burden and needs of transgender populations: a review. Lancet Lond Engl. 2016;388:412–36.

    Article  Google Scholar 

  4. Cohen-Kettenis PT, Gooren LJG. Transsexualism: a review of etiology, diagnosis and treatment. J Psychosom Res. 1999;46:315–33.

    Article  PubMed  CAS  Google Scholar 

  5. GLAAD. GLAAD media reference guide [Internet]. GLAAD. 2011 [cited 2017 Apr 25]. Available from: http://www.glaad.org/reference/.

  6. Katz KA, Furnish TJ. Dermatology-related epidemiologic and clinical concerns of men who have sex with men, women who have sex with women, and transgender individuals. Arch Dermatol. 2005;141:1303–10.

    PubMed  Google Scholar 

  7. Giltay EJ, Gooren LJ. Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab. 2000;85:2913–21.

    Article  PubMed  CAS  Google Scholar 

  8. Dittrich R, Binder H, Cupisti S, Hoffmann I, Beckmann MW, Mueller A. Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc. 2005;113:586–92.

    Article  CAS  Google Scholar 

  9. Gooren LJ, Giltay EJ, Bunck MC. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab. 2008;93:19–25.

    Article  PubMed  CAS  Google Scholar 

  10. Cohen-Kettenis PT, Klink D. Adolescents with gender dysphoria. Best Pract Res Clin Endocrinol Metab. 2015;29:485–95.

    Article  PubMed  Google Scholar 

  11. Spack NP. Management of transgenderism. JAMA. 2013;309:478–84.

    Article  PubMed  CAS  Google Scholar 

  12. Gooren LJ. Care of transsexual persons. N Engl J Med. 2011;364:1251–7.

    Article  PubMed  CAS  Google Scholar 

  13. Randall VA. Androgens and hair growth. Dermatol Ther. 2008;21:314–28.

    Article  PubMed  Google Scholar 

  14. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med. 1999;341:491–7.

    Article  PubMed  CAS  Google Scholar 

  15. Trüeb RM. Molecular mechanisms of androgenetic alopecia. Exp Gerontol. 2002;37:981–90.

    Article  PubMed  Google Scholar 

  16. Jahoda CA, Horne KA, Oliver RF. Induction of hair growth by implantation of cultured dermal papilla cells. Nature. 1984;311:560–2.

    Article  PubMed  CAS  Google Scholar 

  17. Verdier-Sévrain S, Bonté F, Gilchrest B. Biology of estrogens in skin: implications for skin aging. Exp Dermatol. 2006;15:83–94.

    Article  PubMed  CAS  Google Scholar 

  18. Yip L, Rufaut N, Sinclair R. Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: an update of what we now know. Australas J Dermatol. 2011;52:81–8.

    Article  PubMed  Google Scholar 

  19. Fazekas AG, Sandor T. The metabolism of dehydroepiandrosterone by human scalp hair follicles. J Clin Endocrinol Metab. 1973;36:582–6.

    Article  PubMed  CAS  Google Scholar 

  20. Hay JB, Hodgins MB. Distribution of androgen metabolizing enzymes in isolated tissues of human forehead and axillary skin. J Endocrinol. 1978;79:29–39.

    Article  PubMed  CAS  Google Scholar 

  21. Yip L, Sinclair RD. Antiandrogen therapy for androgenetic alopecia. Expert Rev Dermatol. 2006;1:261–9.

    Article  CAS  Google Scholar 

  22. Choudhry R, Hodgins MB, Van der Kwast TH, Brinkmann AO, Boersma WJ. Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol. 1992;133:467–75.

    Article  PubMed  CAS  Google Scholar 

  23. Itami S, Inui S. Role of androgen in mesenchymal epithelial interactions in human hair follicle. J Investig Dermatol Symp Proc. 2005;10:209–11.

    Article  PubMed  CAS  Google Scholar 

  24. Price VH. Testosterone metabolism in the skin: a review of its function in androgenetic alopecia, acne vulgaris, and idiopathic hirsutism including recent studies with antiandrogens. Arch Dermatol. 1975;111:1496–502.

    Article  PubMed  CAS  Google Scholar 

  25. Sawaya ME, Price VH. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol. 1997;109:296–300.

    Article  PubMed  CAS  Google Scholar 

  26. Schweikert HU, Wilson JD. Regulation of human hair growth by steroid hormones. I. Testerone metabolism in isolated hairs. J Clin Endocrinol Metab. 1974;38:811–9.

    Article  PubMed  CAS  Google Scholar 

  27. Gupta M, Mysore V. Classifications of patterned hair loss: a review. J Cutan Aesthet Surg. 2016;9:3–12.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291–303.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13–23.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Wilson JD, Griffin JE, Russell DW. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev. 1993;14:577–93.

    PubMed  CAS  Google Scholar 

  31. Randall VA. Hormonal regulation of hair follicles exhibits a biological paradox. Semin Cell Dev Biol. 2007;18:274–85.

    Article  PubMed  CAS  Google Scholar 

  32. Ohnemus U, Uenalan M, Inzunza J, Gustafsson J-A, Paus R. The hair follicle as an estrogen target and source. Endocr Rev. 2006;27:677–706.

    Article  PubMed  CAS  Google Scholar 

  33. Thornton MJ, Messenger AG, Elliott K, Randall VA. Effect of androgens on the growth of cultured human dermal papilla cells derived from beard and scalp hair follicles. J Invest Dermatol. 1991;97:345–8.

    Article  PubMed  CAS  Google Scholar 

  34. Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68:1359–65.

    Article  PubMed  CAS  Google Scholar 

  35. Olsen EA. Female pattern hair loss. J Am Acad Dermatol. 2001;45:S70–80.

    Article  PubMed  CAS  Google Scholar 

  36. Bulun SE. Clinical review 78: aromatase deficiency in women and men: would you have predicted the phenotypes? J Clin Endocrinol Metab. 1996;81:867–71.

    Article  PubMed  CAS  Google Scholar 

  37. Niiyama S, Happle R, Hoffmann R. Influence of estrogens on the androgen metabolism in different subunits of human hair follicles. Eur J Dermatol EJD. 2001;11:195–8.

    PubMed  CAS  Google Scholar 

  38. Mj Thornton, Taylor AH, Mulligan K, Al-Azzawi F, Lyon CC, O’Driscoll J, et al. The distribution of estrogen receptor β is distinct to that of estrogen receptor α and the androgen receptor in human skin and the pilosebaceous unit. J Investig Dermatol Symp Proc. 2003;8:100–3.

    Article  Google Scholar 

  39. Lynfield YL. Effect of pregnancy on the human hair cycle. J Invest Dermatol. 1960;35:323–7.

    Article  PubMed  CAS  Google Scholar 

  40. Malkud S. Telogen effluvium: a review. J Clin Diagn Res JCDR. 2015;9:WE01–3.

    PubMed  Google Scholar 

  41. Paus R. Therapeutic strategies for treating hair loss. Drug Discov Today Ther Strateg. 2006;3:101–10.

    Article  Google Scholar 

  42. Oh HS, Smart RC. An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc Natl Acad Sci USA. 1996;93:12525–30.

    Article  PubMed  CAS  Google Scholar 

  43. Yip L, Zaloumis S, Irwin D, Severi G, Hopper J, Giles G, et al. Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss. Br J Dermatol. 2009;161:289–94.

    Article  PubMed  CAS  Google Scholar 

  44. Rittmaster RS, Loriaux DL. Hirsutism. Ann Intern Med. 1987;106:95–107.

    Article  PubMed  CAS  Google Scholar 

  45. Leung AKC, Robson WLM. Hirsutism. Int J Dermatol. 1993;32:773–7.

    Article  PubMed  CAS  Google Scholar 

  46. Sachdeva S. Hirsutism: evaluation and treatment. Indian J Dermatol. 2010;55:3–7.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440–7.

    Article  PubMed  CAS  Google Scholar 

  48. Biondo S, Sinclair R. Quality of life in Australian women with female pattern hair loss. Open Dermatol J. 2010;4:90–4.

    Article  Google Scholar 

  49. Norwood OT. Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2001;27:53–4.

    CAS  Google Scholar 

  50. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977;97:247–54.

    Article  PubMed  CAS  Google Scholar 

  51. Norwood OT, Lehr B. Female androgenetic alopecia: a separate entity. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2000;26:679–82.

    CAS  Google Scholar 

  52. Hamilton JB. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci. 1951;53:708–28.

    Article  PubMed  CAS  Google Scholar 

  53. Orme S, Cullen DR, Messenger AG. Diffuse female hair loss: are androgens necessary? Br J Dermatol. 1999;141:521–3.

    Article  PubMed  CAS  Google Scholar 

  54. Wierckx K, Mueller S, Weyers S, Van Caenegem E, Roef G, Heylens G, et al. Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med. 2012;9:2641–51.

    Article  PubMed  CAS  Google Scholar 

  55. Wierckx K, Van de Peer F, Verhaeghe E, Dedecker D, Van Caenegem E, Toye K, et al. Short- and long-term clinical skin effects of testosterone treatment in trans men. J Sex Med. 2014;11:222–9.

    Article  PubMed  CAS  Google Scholar 

  56. Irwig MS. Testosterone therapy for transgender men. Lancet Diabetes Endocrinol. 2017;5:301–11.

    Article  PubMed  CAS  Google Scholar 

  57. Moreno-Arrones OM, Becerra A, Vano-Galvan S. Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients. Clin Exp Dermatol. 2017;42:743–8.

    Article  PubMed  CAS  Google Scholar 

  58. Wierckx K, Van Caenegem E, Schreiner T, Haraldsen I, Fisher AD, Fisher A, et al. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. J Sex Med. 2014;11:1999–2011.

    Article  PubMed  CAS  Google Scholar 

  59. Unger CA. Hormone therapy for transgender patients. Transl Androl Urol. 2016;5:877–84.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Olsen EA, Weiner MS, Amara IA, DeLong ER. Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil. J Am Acad Dermatol. 1990;22:643–6.

    Article  PubMed  CAS  Google Scholar 

  61. Buhl AE. Minoxidil’s action in hair follicles. J Invest Dermatol. 1991;96:S73–4.

    Article  Google Scholar 

  62. Kubilus J, Kvedar JC, Baden HP. Effect of minoxidil on pre- and postconfluent keratinocytes. J Am Acad Dermatol. 1987;16:648–52.

    Article  PubMed  CAS  Google Scholar 

  63. Price VH. Treatment of hair loss. N Engl J Med. 1999;341:964–73.

    Article  PubMed  CAS  Google Scholar 

  64. Katz HI, Hien NT, Prawer SE, Goldman SJ. Long-term efficacy of topical minoxidil in male pattern baldness. J Am Acad Dermatol. 1987;16:711–8.

    Article  PubMed  CAS  Google Scholar 

  65. Rietschel RL, Duncan SH. Safety and efficacy of topical minoxidil in the management of androgenetic alopecia. J Am Acad Dermatol. 1987;16:677–85.

    Article  PubMed  CAS  Google Scholar 

  66. DeVillez RL, Jacobs JP, Szpunar CA, Warner ML. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. Arch Dermatol. 1994;130:303–7.

    Article  PubMed  CAS  Google Scholar 

  67. Jacobs JP, Szpunar CA, Warner ML. Use of topical minoxidil therapy for androgenetic alopecia in women. Int J Dermatol. 1993;32:758–62.

    Article  PubMed  CAS  Google Scholar 

  68. Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50:541–53.

    Article  PubMed  Google Scholar 

  69. Mirmirani P, Consolo M, Oyetakin-White P, Baron E, Leahy P, Karnik P. Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis. Br J Dermatol. 2015;172:1555–61.

    Article  PubMed  CAS  Google Scholar 

  70. Kanti V, Hillmann K, Kottner J, Stroux A, Canfield D, Blume-Peytavi U. Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men: a 104-week open-label clinical trial. J Eur Acad Dermatol Venereol JEADV. 2016;30:1183–9.

    Article  PubMed  CAS  Google Scholar 

  71. Ebner H, Müller E. Allergic contact dermatitis from minoxidil. Contact Dermat. 1995;32:316–7.

    Article  CAS  Google Scholar 

  72. Rittmaster RS. Finasteride. N Engl J Med. 1994;330:120–5.

    Article  PubMed  CAS  Google Scholar 

  73. Kaufman KD. Androgen metabolism as it affects hair growth in androgenetic alopecia. Dermatol Clin. 1996;14:697–711.

    Article  PubMed  CAS  Google Scholar 

  74. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol. 1998;39:578–89.

    Article  PubMed  CAS  Google Scholar 

  75. Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol. 1999;40:930–7.

    Article  PubMed  CAS  Google Scholar 

  76. Hu R, Xu F, Sheng Y, Qi S, Han Y, Miao Y, et al. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Dermatol Ther. 2015;28:303–8.

    Article  PubMed  CAS  Google Scholar 

  77. Ginsberg BA. Dermatologic care of the transgender patient. Int J Womens Dermatol. 2016;3:65–7.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Irwig MS, Kolukula S. Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med. 2011;8:1747–53.

    Article  PubMed  Google Scholar 

  79. Wierckx K, Van Caenegem E, Pennings G, Elaut E, Dedecker D, Van de Peer F, et al. Reproductive wish in transsexual men. Hum Reprod Oxf Engl. 2012;27:483–7.

    Article  Google Scholar 

  80. Frey JD, Poudrier G, Chiodo MV, Hazen A. An update on genital reconstruction options for the female-to-male transgender patient: a review of the literature. Plast Reconstr Surg. 2017;139:728–37.

    Article  PubMed  CAS  Google Scholar 

  81. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974;186:1213–5.

    Article  PubMed  CAS  Google Scholar 

  82. Adenuga P, Summers P, Bergfeld W. Hair regrowth in a male patient with extensive androgenetic alopecia on estrogen therapy. J Am Acad Dermatol. 2012;67:e121–3.

    Article  PubMed  Google Scholar 

  83. Stevenson MO, Wixon N, Safer JD. Scalp hair regrowth in hormone-treated transgender woman. Transgender Health. 2016;1:202–4.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Lynn WS, Brown RH. The conversion of progesterone to androgens by testes. J Biol Chem. 1958;232:1015–30.

    PubMed  CAS  Google Scholar 

  85. Dinh QQ, Sinclair R. Female pattern hair loss: current treatment concepts. Clin Interv Aging. 2007;2:189–99.

    PubMed  PubMed Central  Google Scholar 

  86. Yazdabadi A, Sinclair R. Treatment of female pattern hair loss with the androgen receptor antagonist flutamide. Australas J Dermatol. 2011;52:132–4.

    Article  PubMed  Google Scholar 

  87. Wolf JE, Shander D, Huber F, Jackson J, Lin C-S, Mathes BM, et al. Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. Int J Dermatol. 2007;46:94–8.

    Article  PubMed  CAS  Google Scholar 

  88. Olsen EA, Messenger AG, Shapiro J, Bergfeld WF, Hordinsky MK, Roberts JL, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol. 2005;52:301–11.

    Article  PubMed  Google Scholar 

  89. Capitán L, Simon D, Meyer T, Alcaide A, Wells A, Bailón C, et al. Facial feminization surgery: simultaneous hair transplant during forehead reconstruction. Plast Reconstr Surg. 2017;139:573–84.

    Article  PubMed  CAS  Google Scholar 

  90. Unger WP, Unger RH. Hair transplanting: an important but often forgotten treatment for female pattern hair loss. J Am Acad Dermatol. 2003;49:853–60.

    Article  PubMed  Google Scholar 

  91. Tugnet N, Goddard JC, Vickery RM, Khoosal D, Terry TR. Current management of male-to-female gender identity disorder in the UK. Postgrad Med J. 2007;83:638–42.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Fernandez AA, França K, Chacon AH, Nouri K. From flint razors to lasers: a timeline of hair removal methods. J. Cosmet. Dermatol. 2013;12:153–62.

    Article  PubMed  Google Scholar 

  93. Olsen EA. Methods of hair removal. J Am Acad Dermatol. 1999;40:143–55.

    Article  PubMed  CAS  Google Scholar 

  94. Johnson E, Ebling FJ. The effect of plucking hairs during different phases of the follicular cycle. J Embryol Exp Morphol. 1964;12:465–74.

    PubMed  CAS  Google Scholar 

  95. Shenenberger DW, Utecht LM. Removal of unwanted facial hair. Am Fam Physician. 2002;66:1907–11.

    PubMed  Google Scholar 

  96. Natow AJ. Chemical removal of hair. Cutis. 1986;38:91–2.

    PubMed  CAS  Google Scholar 

  97. Richards RN, Meharg GE. Electrolysis: observations from 13 years and 140,000 hours of experience. J Am Acad Dermatol. 1995;33:662–6.

    Article  PubMed  CAS  Google Scholar 

  98. Pickens JE, Zakhireh M. Permanent removal of unwanted hair. Aesthet Surg J. 2004;24:442–5.

    Article  PubMed  Google Scholar 

  99. Ginsberg BA, Calderon M, Seminara NM, Day D. A potential role for the dermatologist in the physical transformation of transgender people: a survey of attitudes and practices within the transgender community. J Am Acad Dermatol. 2016;74:303–8.

    Article  PubMed  Google Scholar 

  100. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524–7.

    Article  PubMed  CAS  Google Scholar 

  101. Gan SD, Graber EM. Laser hair removal: a review. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2013;39:823–38.

    CAS  Google Scholar 

  102. Görgü M, Aslan G, Aköz T, Erdoğan B. Comparison of alexandrite laser and electrolysis for hair removal. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2000;26:37–41.

    Google Scholar 

  103. Haedersdal M, Wulf HC. Evidence-based review of hair removal using lasers and light sources. J Eur Acad Dermatol Venereol JEADV. 2006;20:9–20.

    Article  PubMed  CAS  Google Scholar 

  104. Zhang WR, Garrett GL, Arron ST, Garcia MM. Laser hair removal for genital gender affirming surgery. Transl Androl Urol. 2016;5:381–7.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Desai S, Mahmoud BH, Bhatia AC, Hamzavi IH. Paradoxical hypertrichosis after laser therapy: a review. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2010;36:291–8.

    CAS  Google Scholar 

  106. Selvaggi G, Bellringer J. Gender reassignment surgery: an overview. Nat Rev Urol. 2011;8:274–82.

    Article  PubMed  Google Scholar 

  107. Bowman C, Goldberg JM. Care of the patient undergoing sex reassignment surgery. Int J Transgenderism. 2006;9:135–65.

    Article  Google Scholar 

  108. Fang RH, Kao YS, Ma S, Lin JT. Phalloplasty in female-to-male transsexuals using free radial osteocutaneous flap: a series of 22 cases. Br J Plast Surg. 1999;52:217–22.

    Article  PubMed  CAS  Google Scholar 

  109. Lawrence AA. Patient-reported complications and functional outcomes of male-to-female sex reassignment surgery. Arch Sex Behav. 2006;35:717–27.

    Article  PubMed  Google Scholar 

  110. Koch D, Pratsou P, Szczecinska W, Lanigan S, Abdullah A. The diverse application of laser hair removal therapy: a tertiary laser unit’s experience with less common indications and a literature overview. Lasers Med Sci. 2015;30:453–67.

    Article  PubMed  CAS  Google Scholar 

  111. Collins F, Biondo S, Sinclair R. Bad hair day: a guide to female hair loss. South Melbourne, Vic: Lothian Books; 2005.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cleveland Clinic Lerner College of Medicine of Case Western University, Cleveland, OH, USA

    Yi Gao

  2. Department of Dermatology, The Permanente Medical Group, 975 Sereno Drive, Vallejo, CA, 94589, USA

    Paradi Mirmirani

  3. Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA

    Toby Maurer & Paradi Mirmirani

Authors
  1. Yi Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toby Maurer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paradi Mirmirani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paradi Mirmirani.

Ethics declarations

Conflict of interest

The authors report no funding source for this article. Mr. Gao and Dr. Maurer declare that they have no conflict of interest. Dr. Mirmirani has been an investigator with Johnson and Johnson and has received research grant funds.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, Y., Maurer, T. & Mirmirani, P. Understanding and Addressing Hair Disorders in Transgender Individuals. Am J Clin Dermatol 19, 517–527 (2018). https://doi.org/10.1007/s40257-018-0343-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-018-0343-z

Search

Navigation